Marcelo C Pasquini, Mei-Jie Zhang, Bruno C Medeiros, Philippe Armand, Zhen-Huan Hu, Taiga Nishihori, Mahmoud D Aljurf, Görgün Akpek, Jean-Yves Cahn, Mitchell S Cairo, Jan Cerny, Edward A Copelan, Abhinav Deol, César O Freytes, Robert Peter Gale, Siddhartha Ganguly, Biju George, Vikas Gupta, Gregory A Hale, Rammurti T Kamble, Thomas R Klumpp, Hillard M Lazarus, Selina M Luger, Jane L Liesveld, Mark R Litzow, David I Marks, Rodrigo Martino, Maxim Norkin, Richard F Olsson, Betul Oran, Attaphol Pawarode, Michael A Pulsipher, Muthalagu Ramanathan, Ran Reshef, Ayman A Saad, Wael Saber, Bipin N Savani, Harry C Schouten, Olle Ringdén, Martin S Tallman, Geoffrey L Uy, William A Wood, Baldeep Wirk, Waleska S Pérez, Minoo Batiwalla, Daniel J Weisdorf
The presence of monosomal karyotype (MK+) in acute myeloid leukemia (AML) is associated with dismal outcomes. We evaluated the impact of MK+ in AML (MK+AML, n = 240) and in myelodysplastic syndrome (MDS) (MK+MDS, n = 221) on hematopoietic cell transplantation outcomes compared with other cytogenetically defined groups (AML, n = 3360; MDS, n = 1373) as reported to the Center for International Blood and Marrow Transplant Research from 1998 to 2011. MK+ AML was associated with higher disease relapse (hazard ratio, 1...
February 2016: Biology of Blood and Marrow Transplantation